A recent study explores an innovative approach to one of medicine's greatest challenges: developing engineered blood components that could one day support emergency transfusion care.
Category: Research Spotlight | Biotechnology | Translational Medicine
Can We Recreate the Most Important Functions of Blood?
Every day, donated blood saves lives. Yet despite decades of advances in medicine, blood remains one of the most difficult biological materials to replace.
Beyond the need for compatible blood types, donated blood has a limited shelf life, requires careful storage, and isn't always immediately available during emergencies or in remote locations.
For years, scientists have searched for ways to overcome these limitations.
A research team in Japan decided to approach the problem differently—not by trying to recreate every component of blood, but by asking a more focused question:
Could they engineer the specific functions that matter most in an emergency?
Study at a Glance
| Research Area | Blood substitutes and transfusion medicine |
| Country | Japan |
| Innovation | Combining artificial oxygen carriers with synthetic platelet substitutes |
| Potential Application | Emergency trauma care |
| Current Stage | Experimental research with ongoing clinical development |
A Different Way to Think About Artificial Blood
One reason artificial blood has remained such a difficult challenge is that blood performs many jobs at once.
Instead of trying to reproduce the entire complexity of blood, the Japanese researchers divided the problem into two essential functions:
- Delivering oxygen to tissues.
- Helping control bleeding.
By engineering each function separately, they hoped to create a system that could eventually support patients experiencing severe blood loss.
The Heart of the Study: Engineering Blood One Function at a Time
The researchers developed tiny hemoglobin vesicles (Hb-V)—microscopic lipid particles containing purified hemoglobin, the same protein responsible for carrying oxygen inside red blood cells.
Why use vesicles instead of free hemoglobin?
Outside red blood cells, free hemoglobin can become unstable and may cause unwanted biological effects. Encapsulating it inside lipid vesicles helps protect the protein while allowing it to function more like a natural oxygen carrier.
The result is an engineered particle designed to transport oxygen without relying on donated red blood cells.
But oxygen delivery alone isn't enough.
Patients experiencing massive blood loss also need to stop bleeding.
To address this challenge, the researchers paired the hemoglobin vesicles with synthetic platelet substitutes, engineered particles designed to promote clot formation where bleeding occurs.
Together, these two technologies form a modular system: one component helps restore oxygen transport, while the other supports hemostasis.
Rather than recreating whole blood, the researchers engineered the functions most critical during trauma care.
Why This Approach Is Different
Artificial blood has been a goal of biomedical research for decades.
Many previous approaches attempted to develop a single product capable of replacing all the functions of blood—a task that has proven extraordinarily difficult.
The Japanese team's strategy is different.
Instead of asking,
"How can we replace blood?"
they asked,
"Which functions are most urgently needed, and can we engineer those first?"
This functional approach reflects a broader trend in biotechnology: solving complex biological problems by designing targeted systems rather than replicating nature in its entirety.
What Did the Researchers Find?
In experimental studies, the engineered blood components demonstrated the ability to support oxygen delivery while the synthetic platelet substitutes contributed to hemostatic function.
The researchers suggest that these technologies could eventually become valuable tools for damage-control resuscitation, particularly in situations where compatible donor blood is not immediately available.
As they wrote:
"Our artificial blood may be useful for damage control resuscitation of trauma-induced massive hemorrhage, especially pre-hospital resuscitation."
While these findings are encouraging, the technology remains under investigation and requires further clinical evaluation before it could become part of routine medical practice.
Why This Research Matters
Although engineered blood substitutes are not ready to replace donated blood, they illustrate how biotechnology is changing the way scientists approach long-standing medical challenges.
Rather than attempting to recreate entire biological systems, researchers are increasingly engineering individual functions that can work together to solve specific clinical problems.
For transfusion medicine, this represents an exciting shift in thinking—one that could eventually expand the options available for emergency and trauma care.
Final Thoughts
Scientific breakthroughs often begin with a simple shift in perspective.
Instead of asking how to replace blood, this research asks a more practical question: Which functions of blood are most important to preserve, and how can we engineer them?
Whether these technologies ultimately reach clinical practice remains to be seen. But they demonstrate how innovative thinking, biomaterials science, and molecular engineering continue to reshape the future of medicine.
Original Research
Kinoshita M., Hagisawa K., Ishida O., Saitoh D., Sakai H., & Takeoka S.
Artificial Blood: Possibility of Future Prehospital Trauma Resuscitation.
Journal of the Japanese Association for the Surgery of Trauma.
DOI: 10.11382/jjast.35.4_05